Equities

Lasa Supergenerics Ltd

Lasa Supergenerics Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (INR)26.19
  • Today's Change-0.80 / -2.96%
  • Shares traded113.94k
  • 1 Year change-3.89%
  • Beta1.3532
Data delayed at least 15 minutes, as of Sep 20 2024 10:59 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of INR
(except for per share items)
Fiscal data as of Mar 31 2024202420232022
ASSETS
Cash And Short Term Investments1524172
Total Receivables, Net7271210
Total Inventory291297278
Prepaid expenses0.570.060.90
Other current assets, total0.501.181.87
Total current assets379392663
Property, plant & equipment, net8639281,251
Goodwill, net117----
Intangibles, net143308168
Long term investments--3.873.84
Note receivable - long term----6.33
Other long term assets7.106.450.00
Total assets1,5091,6392,092
LIABILITIES
Accounts payable14194169
Accrued expenses7.346.968.07
Notes payable/short-term debt000
Current portion long-term debt/capital leases221218202
Other current liabilities, total12010869
Total current liabilities489427447
Total long term debt000
Total debt221218202
Deferred income tax482259
Minority interest------
Other liabilities, total4.746.066.26
Total liabilities542456513
SHAREHOLDERS EQUITY
Common stock501501501
Additional paid-in capital420420420
Retained earnings (accumulated deficit)46262658
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total--0.000.00
Total equity9671,1831,579
Total liabilities & shareholders' equity1,5091,6392,092
Total common shares outstanding505050
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.